From Global Newswire:

The iron deficiency injectable market is booming, with a projected growth from $12.75 billion in 2023 to $14.06 billion in 2024. Experts foresee a further increase to $20.68 billion by 2028. Key players like Daiichi Sankyo and Pfizer are at the forefront of innovation, developing new therapies to address malnutrition. Strategic acquisitions and collaborations, such as CSL Limited’s acquisition of Vifor Pharma, illustrate the industry’s commitment to progress. The market is segmented by type, application, and end-user, offering a range of solutions for various health conditions. Iron deficiency injectables are a crucial tool in combating malnutrition, with the global market poised for continual growth and advancement.



Read more at Global Newswire: Iron Deficiency Injectable Market Size Is Expected To Reach